Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation

Adherence to warfarin treatment among patients with atrial fibrillation

(2014) Mika Skeppholm et al.   Clinical Research in Cardiology

Neuropsychological impact of cerebral microemboli in ablation of atrial fibrillation

(2014) S. Kochhäuser et al.   Clinical Research in Cardiology

Long-term comparison of cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: A propensity score matched analysis

(2014) Sven Knecht et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban

(2013) T. Steiner et al.   Clinical Research in Cardiology

Six Year Follow-Up After Catheter Ablation of Atrial Fibrillation: A Palliation More Than a True Cure

(2012) Antonio Sorgente et al.   AMERICAN JOURNAL OF CARDIOLOGY

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

(2012) Vanessa Roldán et al.   CHEST

Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update

(2012) ANTONIO RAVIELE et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2012) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Silent ischemic lesions in young adults with first stroke are associated with recurrent stroke

(2012) L. C. Gioia et al.   NEUROLOGY

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death

(2011) Ross J Hunter et al.   HEART

Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation

(2011) T. JARED BUNCH et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

CHADS2 and CHA2DS2-VASc Scores in the Prediction of Clinical Outcomes in Patients With Atrial Fibrillation After Catheter Ablation

(2011) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Catheter Ablation for Atrial Fibrillation

(2011) Rukshen Weerasooriya et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Memory after silent stroke: Hippocampus and infarcts both matter

(2011) S. Blum et al.   NEUROLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Recurrence of Atrial Tachyarrhythmias Following Radiofrequency Catheter Ablation of Atrial Fibrillation

(2011) JASON G. ANDRADE et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Microinfarct Pathology, Dementia, and Cognitive Systems

(2011) Zoe Arvanitakis et al.   STROKE

State-of-the-art and emerging technologies for atrial fibrillation ablation

(2010) Jane Dewire et al.   Nature Reviews Cardiology

Newly Identified Events in the RE-LY Trial

(2010) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

(2009) T. Jared Bunch et al.   HEART RHYTHM

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

(2008) Pierre Jaïs et al.   CIRCULATION

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

(2008)   LANCET